688212 澳华内镜
已收盘 11-06 15:00:00
资讯
新帖
简况
澳华内镜（688212）11月5日主力资金净卖出1130.46万元
证券之星 · 08:13
澳华内镜（688212）11月5日主力资金净卖出1130.46万元
澳华内镜新注册《支气管镜辅助质控软件V1.2》项目的软件著作权
证券之星 · 11-05 05:42
澳华内镜新注册《支气管镜辅助质控软件V1.2》项目的软件著作权
股市必读：澳华内镜（688212）11月4日董秘有最新回复
证券之星 · 11-05 02:29
股市必读：澳华内镜（688212）11月4日董秘有最新回复
股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》
证券之星 · 11-04 04:03
股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》
中银证券：首次覆盖澳华内镜给予买入评级
证券之星 · 11-03 20:45
中银证券：首次覆盖澳华内镜给予买入评级
股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》
证券之星 · 11-03
股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》
11月2日澳华内镜涨5.09%，申万菱信多策略灵活配置混合A基金重仓该股
证券之星 · 11-02
11月2日澳华内镜涨5.09%，申万菱信多策略灵活配置混合A基金重仓该股
股市必读：澳华内镜（688212）10月30日披露最新机构调研信息
证券之星 · 11-02
股市必读：澳华内镜（688212）10月30日披露最新机构调研信息
【机构调研记录】明亚基金调研百克生物、澳华内镜
证券之星 · 11-02
【机构调研记录】明亚基金调研百克生物、澳华内镜
【私募调研记录】重阳投资调研澳华内镜
证券之星 · 11-02
【私募调研记录】重阳投资调研澳华内镜
澳华内镜：10月27日召开业绩说明会，包括知名机构高毅资产的多家机构参与
同花顺 · 10-31
澳华内镜：10月27日召开业绩说明会，包括知名机构高毅资产的多家机构参与
澳华内镜（688212）2026年三季报简析：增收不增利，应收账款上升
证券之星 · 10-28
澳华内镜（688212）2026年三季报简析：增收不增利，应收账款上升
股市必读：澳华内镜三季报 - 第三季度单季净利润同比增长20.22%
证券之星 · 10-28
股市必读：澳华内镜三季报 - 第三季度单季净利润同比增长20.22%
澳华内镜(688212)9月30日股东户数0.84万户，较上期增加10.43%
证券之星 · 10-27
澳华内镜(688212)9月30日股东户数0.84万户，较上期增加10.43%
澳华内镜(688212.SH)发布前三季度业绩，归母净亏损9785万元
智通财经 · 10-26
澳华内镜(688212.SH)发布前三季度业绩，归母净亏损9785万元
10月23日澳华内镜涨12.00%，金信消费升级股票A基金重仓该股
证券之星 · 10-23
10月23日澳华内镜涨12.00%，金信消费升级股票A基金重仓该股
股市必读：澳华内镜（688212）10月22日董秘有最新回复
证券之星 · 10-23
股市必读：澳华内镜（688212）10月22日董秘有最新回复
每周股票复盘：澳华内镜（688212）ERCP手术机器人国内多中心临床推进中
证券之星 · 09-20
每周股票复盘：澳华内镜（688212）ERCP手术机器人国内多中心临床推进中
澳华内镜：2026年第一次临时股东会决议公告
证券日报网 · 09-18
澳华内镜：2026年第一次临时股东会决议公告
澳华内镜：9月15日接受机构调研，富国基金、中哲物产投资等多家机构参与
证券之星 · 09-16
澳华内镜：9月15日接受机构调研，富国基金、中哲物产投资等多家机构参与
加载更多
公司概况
公司名称：
上海澳华内镜股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-11-15
主营业务：
上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内镜主机（含图像处理器和光源）、内镜镜体、内镜周边设备、非血管支架、基础类耗材。
发行价格：
22.50
{"stockData":{"symbol":"688212","market":"SH","secType":"STK","nameCN":"澳华内镜","latestPrice":28.31,"timestamp":1793948400000,"preClose":28.93,"halted":0,"volume":1990927,"delay":0,"changeRate":-0.0214,"floatShares":135000000,"shares":135000000,"eps":-0.2251,"marketStatus":"已收盘","change":-0.62,"latestTime":"11-06 15:00:00","open":28.36,"high":28.83,"low":28,"amount":56537800,"amplitude":0.0287,"askPrice":28.31,"askSize":1,"bidPrice":28.3,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-0.2251,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":28.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":31.82,"lowLimit":26.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134665250,"isCdr":false,"pbRate":3.15,"roa":"--","roe":"--","epsLYR":0.09,"committee":0.846154,"marketValue":3812000000,"turnoverRate":0.0148,"status":1,"afterMarket":{"amount":0,"volume":0,"close":28.31,"buyVolume":6414,"sellVolume":0,"time":1793950437746,"indexStatus":"已收盘 11-06 15:30:00","preClose":28.93},"floatMarketCap":3812000000},"requestUrl":"/m/hq/s/688212","defaultTab":"news","newsList":[{"id":"2681881972","title":"澳华内镜（688212）11月5日主力资金净卖出1130.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681881972","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681881972?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:13","pubTimestamp":1793924025,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月5日收盘，澳华内镜报收于28.93元，上涨9.01%，换手率3.77%，成交量5.08万手，成交额1.44亿元。11月5日的资金流向数据方面，主力资金净流出1130.46万元，占总成交额7.87%，游资资金净流入762.79万元，占总成交额5.31%，散户资金净流入367.68万元，占总成交额2.56%。融券方面，融券卖出0.0股，融券偿还0.0股，融券余量6496.0股，融券余额18.79万元。澳华内镜主营业务：电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681095393","title":"澳华内镜新注册《支气管镜辅助质控软件V1.2》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2681095393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681095393?lang=zh_cn&edition=full","pubTime":"2026-11-05 05:42","pubTimestamp":1793828540,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜（688212）新注册了《支气管镜辅助质控软件V1.2》项目的软件著作权。今年以来澳华内镜新注册软件著作权8个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了7040.52万元，同比减4.61%。通过天眼查大数据分析，上海澳华内镜股份有限公司共对外投资了9家企业，参与招投标项目996次；财产线索方面有商标信息37条，专利信息296条，著作权信息23条；此外企业还拥有行政许可468个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500006607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","159180","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681615750","title":"股市必读：澳华内镜（688212）11月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2681615750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681615750?lang=zh_cn&edition=full","pubTime":"2026-11-05 02:29","pubTimestamp":1793816961,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘，澳华内镜报收于26.54元，下跌1.15%，换手率2.32%，成交量3.12万手，成交额8232.57万元。董秘最新回复投资者： 董秘您好，请问能否告知公司董事长兼总经理顾小舟的毕业院校？公司董事及高级管理人员的履历情况详见公司披露的定期报告。公司将结合自身经营发展及人才培养需求，适时开展校企合作相关工作。当日关注点交易信息汇总：11月4日主力资金净流入380.93万元，占总成交额4.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500004353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680748347","title":"股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680748347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680748347?lang=zh_cn&edition=full","pubTime":"2026-11-04 04:03","pubTimestamp":1793736214,"startTime":"0","endTime":"0","summary":"公司公告汇总关于变更持续督导保荐代表人的公告上海澳华内镜股份有限公司于2026年11月2日收到中信证券出具的《关于更换保荐代表人的函》。变更后，公司持续督导保荐代表人为慎利亚先生和罗伟豪先生，持续督导期至中国证监会和上交所规定的义务结束为止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680296827","title":"中银证券：首次覆盖澳华内镜给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2680296827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680296827?lang=zh_cn&edition=full","pubTime":"2026-11-03 20:45","pubTimestamp":1793709902,"startTime":"0","endTime":"0","summary":"中银国际证券股份有限公司刘恩阳,苏雪儿近期对澳华内镜进行研究并发布了研究报告《营收增长稳健，利润短期承压》，首次覆盖澳华内镜给予买入评级。 澳华内镜 公司公布2026年三季报，2026年前三季度实现营业收入4.55亿元，同比增长7.62%；归母净利润亏损9,784.74万元，上年同期亏损5,609.25万元；扣非归母净利润亏损1.04亿元。首次覆盖，给予买入评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300039978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","601696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680767832","title":"股市必读：澳华内镜新发布《关于变更持续督导保荐代表人的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680767832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680767832?lang=zh_cn&edition=full","pubTime":"2026-11-03 02:53","pubTimestamp":1793645639,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，澳华内镜报收于27.85元，上涨5.09%，换手率1.76%，成交量2.37万手，成交额6529.56万元。当日关注点交易信息汇总：11月2日主力资金净流出166.49万元，占总成交额2.55%。公司公告汇总：澳华内镜于2026年11月2日公告变更持续督导保荐代表人，罗伟豪先生接替徐峰林先生，与慎利亚先生共同履行持续督导职责。变更后，公司持续督导保荐代表人为慎利亚先生和罗伟豪先生，持续督导期至中国证监会和上交所规定的义务结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300004915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680737507","title":"11月2日澳华内镜涨5.09%，申万菱信多策略灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680737507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680737507?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:11","pubTimestamp":1793610681,"startTime":"0","endTime":"0","summary":"证券之星消息，11月2日澳华内镜涨5.09%，收盘报27.85元，换手率1.76%，成交量2.37万手，成交额6529.56万元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共16家，其中持有数量最多的公募基金为申万菱信基金的申万菱信多策略灵活配置混合A。申万菱信多策略灵活配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200024670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","160921","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680785810","title":"股市必读：澳华内镜（688212）10月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2680785810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680785810?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:06","pubTimestamp":1793577968,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，澳华内镜报收于26.5元，下跌2.86%，换手率2.22%，成交量2.99万手，成交额8021.85万元。当日关注点交易信息汇总：10月30日主力资金净流入501.45万元，占总成交额6.25%。ERCP机器人国内NMPA注册证预计2027年Q3取得；CE及FDA认证同步推进；上述时间为当前规划节点，受审评核查、临床反馈等因素影响存在不确定性，项目整体推进计划暂无调整。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200002335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680678538","title":"【机构调研记录】明亚基金调研百克生物、澳华内镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2680678538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680678538?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:04","pubTimestamp":1793577883,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月30日披露的机构调研信息，明亚基金近期对2家上市公司进行了调研，相关名单如下：1）百克生物 调研纪要：前三季度，公司实现营业收入56,383.72万元，同比增长18.84%；实现归属于上市公司股东的净利润-9,562.55万元，同比减亏6,262.50万元。流感疫苗及带状疱疹疫苗销量增加带动盈利改善。明亚基金成立于2019年，截至目前，资产管理规模15.62亿元；资产管理规模15.62亿元；管理公募基金数18只；旗下公募基金经理5人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200002278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688212","688276","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680830567","title":"【私募调研记录】重阳投资调研澳华内镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2680830567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680830567?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:01","pubTimestamp":1793577677,"startTime":"0","endTime":"0","summary":"根据市场公开信息及10月30日披露的机构调研信息，知名私募重阳投资近期对1家上市公司进行了调研，相关名单如下：1）澳华内镜 调研纪要：2026年第三季度医院招采情况较好，第四季度为软镜行业传统采购旺季，公司将持续推进三级医院覆盖及Q-300、Q-400高端机型院内准入、入院落地相关工作。在投资方法上，重阳投资注重研究驱动的投资，强调严谨科学的投资流程在投资中的重要性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026110200002180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679242567","title":"澳华内镜：10月27日召开业绩说明会，包括知名机构高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2679242567","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679242567?lang=zh_cn&edition=full","pubTime":"2026-10-31 03:07","pubTimestamp":1793387220,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年10月30日澳华内镜(688212)发布公告称公司于2026年10月27日召开业绩说明会，富国基金、中金公司、环懿投资、华鑫证券、华夏基金、华西证券、华泰证券、渤海人寿保险、博 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261031/c681316925.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261031/c681316925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678467003","title":"澳华内镜（688212）2026年三季报简析：增收不增利，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2678467003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678467003?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:16","pubTimestamp":1793189792,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期澳华内镜发布2026年三季报。按单季度数据看，第三季度营业总收入1.75亿元，同比上升8.02%，第三季度归母净利润-1222.77万元，同比上升20.22%。本报告期澳华内镜应收账款上升，应收账款同比增幅达32.24%。持有澳华内镜最多的基金为申万菱信多策略灵活配置混合A，目前规模为5.19亿元，最新净值2.452，较上一交易日下跌2.04%，近一年上涨14.08%。本文数据来源于澳华内镜2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800046824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678885644","title":"股市必读：澳华内镜三季报 - 第三季度单季净利润同比增长20.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678885644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678885644?lang=zh_cn&edition=full","pubTime":"2026-10-28 03:55","pubTimestamp":1793130920,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，澳华内镜报收于27.58元，下跌5.55%，换手率1.82%，成交量2.45万手，成交额6952.75万元。业绩披露要点：2026年前三季度归母净利润为-9784.74万元，同比下降74.44%；第三季度单季度归母净利润为-1222.77万元，同比上升20.22%。2026年第三季度单季度主营收入1.75亿元，同比上升8.02%；单季度归母净利润-1222.77万元，同比上升20.22%；单季度扣非净利润-1586.28万元，同比上升2.96%；负债率38.35%，投资收益-18.48万元，财务费用1068.84万元，毛利率65.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800004106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678752173","title":"澳华内镜(688212)9月30日股东户数0.84万户，较上期增加10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678752173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678752173?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:36","pubTimestamp":1793097376,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜披露，截至2026年9月30日公司股东户数为8366.0户，较6月30日增加790.0户，增幅为10.43%。在医疗器械行业个股中，澳华内镜股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.08万户。从股价来看，2026年6月30日至2026年9月30日，澳华内镜区间跌幅为4.35%，在此期间股东户数增加790.0户，增幅为10.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678199224","title":"澳华内镜(688212.SH)发布前三季度业绩，归母净亏损9785万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678199224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678199224?lang=zh_cn&edition=full","pubTime":"2026-10-26 21:49","pubTimestamp":1793022550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，澳华内镜(688212.SH)披露2026年第三季度报告，前三季度公司实现营收4.55亿元，同比增长7.62%，归母净利润亏损9785万元，扣非净利润亏损1.04亿元;基本每股收益-0.73元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677094415","title":"10月23日澳华内镜涨12.00%，金信消费升级股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677094415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677094415?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:40","pubTimestamp":1792744811,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日澳华内镜涨12.00%，收盘报28.65元，换手率4.59%，成交量6.19万手，成交额1.69亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为金信基金的金信消费升级股票A。金信消费升级股票A目前规模为0.39亿元，最新净值1.3259，较上一交易日下跌1.12%，近一年下跌22.23%。金信消费升级股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677942619","title":"股市必读：澳华内镜（688212）10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677942619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677942619?lang=zh_cn&edition=full","pubTime":"2026-10-23 05:09","pubTimestamp":1792703354,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，澳华内镜报收于25.58元，上涨0.91%，换手率1.83%，成交量2.46万手，成交额6461.78万元。董秘最新回复投资者： 尊敬的董秘，贵司手术机器人目前是否完成入组测试？公司ERCP手术机器人全球多中心临床试验入组工作正有序推进。当日关注点交易信息汇总：10月22日主力资金净流出35.69万元，占总成交额0.55%；游资资金净流入506.04万元，占总成交额7.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668909850","title":"每周股票复盘：澳华内镜（688212）ERCP手术机器人国内多中心临床推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2668909850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668909850?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:44","pubTimestamp":1789839852,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，澳华内镜报收于27.6元，较上周的27.9元下跌1.08%。本周关注点来自机构调研要点：ERCP手术机器人国内临床正于头部医院多中心同步推进。机构调研要点问：新产品ERCP手术机器人在国内市场最新的临床进展？整体包含基础ERCP手术操作费用、配套耗材费用以及后续机器人辅助操作相关医疗服务费用。ERCP手术机器人销售推广科室和现有软镜业务同属消化科，整体销售费用占营业收入的比例趋向可控。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668924889","title":"澳华内镜：2026年第一次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2668924889","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668924889?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:06","pubTimestamp":1789736760,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月18日，澳华内镜发布公告称，公司于2026年9月18日召开2026年第一次临时股东会，审议通过《关于使用部分超募资金永久补充流动资金的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-18/doc-inishkur3087811.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-18/doc-inishkur3087811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667350986","title":"澳华内镜：9月15日接受机构调研，富国基金、中哲物产投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667350986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667350986?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:09","pubTimestamp":1789564198,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月16日澳华内镜发布公告称公司于2026年9月15日接受机构调研，富国基金、中哲物产投资、华宝自营、国联基金、前海开源基金、贺腾资产、中域资产、睿扬投资、鹏华基金、国寿安保基金、杭银理财、长信基金、深圳茗辉基金、上海原点资产、DNB Carnegie、上海聂丰私募、中金资管、招银理财、金信基金、红塔红土参与。整体包含基础ERCP手术操作费用、配套耗材费用以及后续机器人辅助操作相关医疗服务费用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793963677611,"stockEarnings":[{"period":"1week","weight":0.0605},{"period":"1month","weight":0.0288},{"period":"3month","weight":0.0528},{"period":"6month","weight":-0.2221},{"period":"1year","weight":-0.3897},{"period":"ytd","weight":-0.3381}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海澳华内镜股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"8366人(较上一季度增加10.43%)","perCapita":"16096股","listingDate":"2021-11-15","address":"上海市闵行区光中路133弄66号","registeredCapital":"13466万元","survey":" 上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内镜主机（含图像处理器和光源）、内镜镜体、内镜周边设备、非血管支架、基础类耗材。","listedPrice":22.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"澳华内镜,688212,澳华内镜股票,澳华内镜股票老虎,澳华内镜股票老虎国际,澳华内镜行情,澳华内镜股票行情,澳华内镜股价,澳华内镜股市,澳华内镜股票价格,澳华内镜股票交易,澳华内镜股票购买,澳华内镜股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}